Wellington Management Group LLP Agios Pharmaceuticals, Inc. Transaction History

Wellington Management Group LLP

$503 Billion
Q1 2025

A detailed history of Wellington Management Group LLP transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 24,462 shares of AGIO stock, worth $882,344. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,462

Holding current value

$882,344

% of portfolio

0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$29.3 - $35.9 $716,736 - $878,185	24,462 New	24,462 $716,000
Q4 2024 Feb 12, 2025	SELL	$32.86 - $61.64 $130,092 - $244,032	-3,959 Reduced 13.44%	25,489 $837,000
Q3 2024 Nov 14, 2024	SELL	$41.19 - $49.72 $287,135 - $346,598	-6,971 Reduced 19.14%	29,448 $1.31 Million
Q2 2024 Aug 13, 2024	SELL	$27.55 - $48.83 $94,358 - $167,242	-3,425 Reduced 8.6%	36,419 $1.57 Million
Q1 2024 May 15, 2024	BUY	$21.32 - $34.81 $849,474 - $1.39 Million	39,844 New	39,844 $1.17 Million
Q4 2023 Feb 12, 2024	BUY	$19.97 - $24.53 $907,975 - $1.12 Million	45,467 New	45,467 $1.01 Million
Q3 2023 Nov 14, 2023	SELL	$24.36 - $28.18 $16.2 Million - $18.8 Million	-666,565 Reduced 11.36%	5,199,063 $129 Million
Q2 2023 Aug 14, 2023	BUY	$21.38 - $29.19 $3.05 Million - $4.16 Million	142,497 Added 2.49%	5,865,628 $166 Million
Q1 2023 May 12, 2023	BUY	$21.74 - $30.93 $5.66 Million - $8.06 Million	260,474 Added 4.77%	5,723,131 $131 Million
Q4 2022 Feb 13, 2023	BUY	$24.81 - $31.52 $7.8 Million - $9.9 Million	314,244 Added 6.1%	5,462,657 $153 Million
Q2 2022 Aug 15, 2022	SELL	$17.06 - $31.42 $2,610 - $4,807	-153 Reduced -0.0%	5,148,413 $114 Million
Q4 2021 Feb 11, 2022	SELL	$29.58 - $49.78 $999,419 - $1.68 Million	-33,787 Reduced 0.65%	5,148,566 $169 Million
Q3 2021 Nov 15, 2021	SELL	$41.92 - $58.18 $66.5 Million - $92.4 Million	-1,587,362 Reduced 23.45%	5,182,353 $239 Million
Q2 2021 Aug 16, 2021	SELL	$52.06 - $61.27 $4.37 Million - $5.14 Million	-83,881 Reduced 1.22%	6,769,715 $373 Million
Q1 2021 May 17, 2021	SELL	$44.23 - $57.5 $45.3 Million - $58.9 Million	-1,023,774 Reduced 13.0%	6,853,596 $354 Million
Q4 2020 Feb 12, 2021	SELL	$33.21 - $46.54 $1.09 Million - $1.53 Million	-32,838 Reduced 0.42%	7,877,370 $341 Million
Q3 2020 Nov 16, 2020	BUY	$33.87 - $55.93 $1.47 Million - $2.42 Million	43,331 Added 0.55%	7,910,208 $277 Million
Q2 2020 Aug 14, 2020	SELL	$34.45 - $53.48 $473,480 - $735,029	-13,744 Reduced 0.17%	7,866,877 $421 Million
Q1 2020 May 14, 2020	SELL	$31.52 - $53.81 $2.56 Million - $4.36 Million	-81,102 Reduced 1.02%	7,880,621 $280 Million
Q4 2019 Feb 11, 2020	BUY	$30.08 - $50.59 $239 Million - $403 Million	7,961,723 New	7,961,723 $380 Million

Others Institutions Holding AGIO

# of Institutions

237

Shares Held

60.1M

Call Options Held

323K

Put Options Held

367K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.98B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Agios Pharmaceuticals, Inc. Transaction History